Citation: Lvm. Rao et al., ANTIBODY-INDUCED ACUTE FACTOR-X DEFICIENCY - CLINICAL MANIFESTATIONS AND PROPERTIES OF THE ANTIBODY, Thrombosis and haemostasis, 72(3), 1994, pp. 363-371
Authors:
BLOMBACK M
ABILDGAARD U
VANDENBESSELAAR AMHP
CLEMENTSON KJ
DAHLBACK B
EXNER T
FRANCIS CW
GAFFNEY P
GRALNICK H
HOYER LW
JOHNSON GJ
KASPER C
LANE D
LIJNEN HR
LUSHER JM
MANNUCCI PM
POLLER L
RAPAPORT SI
SAITO H
STOCKER K
THOMAS D
BARROWCLIFFE TW
HEMKER C
THORSEN S
ARONSON D
MANN KG
MEYER D
ROBERTS HR
DYBKAER R
JORGENSEN K
OLESEN H
Citation: M. Blomback et al., NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY, Thrombosis and haemostasis, 71(3), 1994, pp. 375-394
Citation: Lvm. Rao et al., DIFFERENCES IN THE INTERACTIONS OF LUPUS ANTICOAGULANT IGG WITH HUMANVERSUS BOVINE PROTHROMBIN, Blood, 84(10), 1994, pp. 10000068-10000068
Authors:
LE DT
GRIFFIN JH
GREENGARD JS
RAPAPORT SI
Citation: Dt. Le et al., A PROTHROMBIN TIME-BASED ASSAY FOR ACTIVATED PROTEIN-C (APC) RESISTANT FACTOR-V (FV) IN PATIENTS ON WARFARIN OR WITH A LUPUS ANTICOAGULANT, Blood, 84(10), 1994, pp. 10000084-10000084
Citation: P. Permpikul et al., FUNCTIONAL AND BINDING-STUDIES OF THE ROLES OF PROTHROMBIN AND BETA-2-GLYCOPROTEIN-I IN THE EXPRESSION OF LUPUS ANTICOAGULANT ACTIVITY, Blood, 83(10), 1994, pp. 2878-2892
Authors:
LE DT
WEIBERT RT
SEVILLA BK
DONNELLY KJ
RAPAPORT SI
Citation: Dt. Le et al., THE INTERNATIONAL NORMALIZED RATIO (INR) FOR MONITORING WARFARIN THERAPY - RELIABILITY AND RELATION TO OTHER MONITORING METHODS, Annals of internal medicine, 120(7), 1994, pp. 552-558
Citation: Bj. Warncramer et Si. Rapaport, STUDIES OF FACTOR-XA PHOSPHOLIPID INDUCED INTRAVASCULAR COAGULATION IN RABBITS - EFFECTS OF IMMUNODEPLETION OF TISSUE FACTOR PATHWAY INHIBITOR, Arteriosclerosis and thrombosis, 13(11), 1993, pp. 1551-1557
Citation: A. Zivelin et al., REDUCTION OF BOTH FACTOR-II AND FACTOR-X IS REQUIRED FOR WARFARIN TO PROTECT RABBITS AGAINST TISSUE FACTOR-INDUCED INTRAVASCULAR COAGULATION, Thrombosis and haemostasis, 69(6), 1993, pp. 588-588
Citation: Dt. Le et al., ROLE OF ANIONIC PHOSPHOLIPID ON THE CELL-SURFACE IN MODULATION OF FACTOR-VIIA TISSUE FACTOR ACTIVATION OF FACTOR-X, Thrombosis and haemostasis, 69(6), 1993, pp. 742-742
Citation: P. Permpikul et al., INTERACTION OF LUPUS ANTICOAGULANT WITH PROTHROMBIN AND B2-GLYCOPROTEIN-I, Thrombosis and haemostasis, 69(6), 1993, pp. 1011-1011
Citation: Bj. Warncramer et Si. Rapaport, ADMINISTRATION OF FACTOR-XA PHOSPHOLIPID TO RABBITS RESULTS IN REDUCED PLASMA-LEVELS OF FACTOR-X, FACTOR-IX, FACTOR-XI, AND FACTOR-XII, Thrombosis and haemostasis, 69(6), 1993, pp. 1307-1307
Citation: A. Zivelin et al., MECHANISM OF THE ANTICOAGULANT EFFECT OF WARFARIN AS EVALUATED IN RABBITS BY SELECTIVE DEPRESSION OF INDIVIDUAL PROCOAGULANT VITAMIN-K-DEPENDENT CLOTTING FACTORS, The Journal of clinical investigation, 92(5), 1993, pp. 2131-2140
Citation: Lvm. Rao et al., STUDIES OF THE BINDING OF LUPUS ANTICOAGULANT IGG TO PROTHROMBIN, BETA-2-GLYCOPROTEIN-I AND PHOSPHATIDYLSERINE, Blood, 82(10), 1993, pp. 10000405-10000405
Citation: Lvm. Rao et al., BINDING OF FACTOR-VIIA TO TISSUE FACTOR PERMITS RAPID ANTITHROMBIN-III HEPARIN INHIBITION OF FACTOR-VIIA, Blood, 81(10), 1993, pp. 2600-2607